July 1, 2026
RIVANNA expands multi-site clinical study for Accuro XV musculoskeletal imaging system
B Company accelerates AI-enabled fracture detection development, compressing anticipated FDA 510(k) timeline CHARLOTTESVILLE, Va., April 22, 2026 /PRNewswire/ — RIVANNA®, developer of AI-enabled clinical decision-support…
